High D-glucose induces alterations of endothelial cell structure in a cell-culture model

A Salameh1, M Zinn, S Dhein

  • 1Klinik III für Innere Medizin, Köln, Germany.

Insights

High glucose levels in diabetes damage endothelial cells, altering their structure. Celiprolol treatment reversed these harmful effects, suggesting a potential therapeutic benefit for managing diabetic complications.

Area of Science:

  • Endothelial cell biology
  • Diabetic microvascular complications
  • Pharmacology

Background:

  • Diabetes mellitus is characterized by micro- and macroangiopathy, often involving endothelial dysfunction.
  • Hyperglycemia directly impacts endothelial cell structure and function, contributing to disease progression.

Purpose of the Study:

  • To investigate the direct effects of high glucose on endothelial cell morphology and function.
  • To evaluate the potential protective effects of celiprolol and nitrendipine against high glucose-induced endothelial damage.

Main Methods:

  • Endothelial cells were cultured and exposed to varying concentrations of D-glucose (5 mM and 20 mM) with or without celiprolol or nitrendipine.
  • Cellular structure was assessed using hematoxylin-eosin, NADPH-diaphorase, and actin staining.
  • Quantitative analysis of cell, cytoplasm, and nuclear areas, as well as cell counts, was performed.

Main Results:

  • Exposure to 20 mM D-glucose significantly increased cell size and the number of giant/polynuclear cells, while reducing nuclear area and NADPH-diaphorase activity.
  • Celiprolol treatment effectively reversed most high glucose-induced structural changes in endothelial cells.
  • Nitrendipine showed no beneficial effect on high glucose-induced endothelial cell alterations.

Conclusions:

  • Prolonged exposure to high glucose induces significant structural damage to endothelial cells.
  • Celiprolol demonstrates a protective effect against hyperglycemia-induced endothelial cell alterations, suggesting its potential therapeutic value.
  • Nitrendipine did not mitigate the observed detrimental effects of high glucose on endothelial cells.

Related Concept Videos

Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...